Federated Hermes’s Neuronetics STIM Stock Holding History

Federated Hermes’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-465	Closed	-$1.35K	–	2220
2023 Q1	$1.35K	Sell	465 -142	-23%	-$716	﹤0.01%	2028
2022 Q4	$4.17K	Sell	607 -735	-55%	-$3.47K	﹤0.01%	1943
2022 Q3	$4K	Sell	1,342 -1,014	-43%	-$3.69K	﹤0.01%	1917
2022 Q2	$8K	Buy	2,356 +467	+25%	+$1.36K	﹤0.01%	1853
2022 Q1	$6K	Buy	+1,889	New	+$6.38K	﹤0.01%	1942
2021 Q2	–	Sell	-53	Closed	-$1K	–	2328
2021 Q1	$1K	Sell	53 -462	-90%	-$7.08K	﹤0.01%	2191
2020 Q4	$6K	Sell	515 -69	-12%	-$519	﹤0.01%	2037
2020 Q3	$3K	Sell	584 -2,218	-79%	-$8.41K	﹤0.01%	2075
2020 Q2	$5K	Buy	2,802 +1,528	+120%	+$3.13K	﹤0.01%	2003
2020 Q1	$2K	Sell	1,274 -5,090	-80%	-$15.9K	﹤0.01%	2039
2019 Q4	$29K	Buy	+6,364	New	+$39.5K	﹤0.01%	1796

Other funds holding STIM

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

KLC

Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

BGIM

Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return

FWC

First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return

Federated Hermes's STIM Position: Q2 2023 in Review

Federated Hermes sold out of Neuronetics (STIM) in Q2 2023, closing a stake of 465 shares — an estimated $1.35K sold.

Federated Hermes first reported a position in STIM in Q4 2019 and held it in 11 quarters. The position peaked at $29K in Q4 2019. 69 funds tracked by Wall St. Rank hold STIM as of Q2 2023.

Federated Hermes reported no remaining Neuronetics position as of Q2 2023 after selling out during the quarter.
Federated Hermes sold 465 Neuronetics shares in Q2 2023, an estimated $1.35K.
Federated Hermes first reported a position in Neuronetics in Q4 2019 and held it in 11 quarters.
Federated Hermes's Neuronetics position peaked at $29K in Q4 2019.
69 funds tracked by Wall St. Rank held Neuronetics as of Q2 2023.

Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.